Tempus AI (TEM) versus Its Rivals Financial Comparison

Tempus AI (NASDAQ:TEM) is one of 120 public companies in the “Computer programming, data processing, & other computer related” industry, but how does it weigh in compared to its rivals? We will compare Tempus AI to similar businesses based on the strength of its earnings, institutional ownership, valuation, analyst recommendations, dividends, profitability and risk.

Profitability

This table compares Tempus AI and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tempus AI	N/A	N/A	-111.38%
Tempus AI Competitors	-138.86%	-18.64%	-3.29%

Valuation & Earnings

This table compares Tempus AI and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Tempus AI	$803.32 million	-$289.81 million	-7.60
Tempus AI Competitors	$11.62 billion	$2.53 billion	-35,285.54

Tempus AI’s rivals have higher revenue and earnings than Tempus AI. Tempus AI is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

24.2% of Tempus AI shares are owned by institutional investors. Comparatively, 48.7% of shares of all “Computer programming, data processing, & other computer related” companies are owned by institutional investors. 27.6% of Tempus AI shares are owned by insiders. Comparatively, 17.3% of shares of all “Computer programming, data processing, & other computer related” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Tempus AI and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	0	6	7	0	2.54
Tempus AI Competitors	1315	5226	11558	350	2.59

Tempus AI presently has a consensus price target of $63.42, suggesting a potential upside of 7.03%. As a group, “Computer programming, data processing, & other computer related” companies have a potential upside of 20.69%. Given Tempus AI’s rivals stronger consensus rating and higher possible upside, analysts clearly believe Tempus AI has less favorable growth aspects than its rivals.

Summary

Tempus AI rivals beat Tempus AI on 8 of the 12 factors compared.

Tempus AI Company Profile

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.